Status
Conditions
Treatments
About
This registry aims to evaluate the long-term prognosis and valve durability of transcatheter aortic valve replacement (TAVR) in a real-world setting. Baseline characteristics, procedural data, and clinical outcomes will be collected in a prospective and observational manner.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients diagnosed with severe aortic valve regurgitation undergo evaluation by the Heart team and are eligible for TAVR therapy.
Exclusion criteria
Loading...
Central trial contact
Rutao Wang, M.D, Ph.D
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal